Results 51 to 60 of about 216,260 (210)

Clinical failure of vancomycin treatment of Staphylococcus aureus infection in a tertiary care hospital in southern Brazil

Brazilian Journal of Infectious Diseases
We describe a case of clinical failure of vancomycin treatment of Staphylococcus aureus infection and the laboratory characteristics of the organism in a tertiary referral university hospital in southern Brazil.
Larissa Lutz, Adão Machado, Nadia Kuplich, Afonso Luís Barth   +3 more
doaj   +1 more source

Rash induced by enteral vancomycin therapy in an older patient in a long-term care ventilator unit: case report and review of the literature

Allergy, Asthma & Clinical Immunology, 2018
Background Oral vancomycin is a first-line treatment for severe Clostridium difficile colitis. Oral vancomycin is perceived to lack systemic absorption or systemic adverse effects; however, a few cases of hypersensitivity to oral vancomycin have been ...
Jeremy Barron, Adolfo Lattes, Esther-Lee Marcus   +2 more
doaj   +1 more source

Does local vancomycin powder impregnated with autogenous bone graft and bone substitute decrease the risk of deep surgical site infection in degenerative lumbar spine fusion surgery?—An ambispective study

BMC Musculoskeletal Disorders, 2022
Background Deep surgical site infection (DSSI) is one of the most challenging complications in lumbar fusion surgery. Few investigations examined the effect of vancomycin powder mixed with autogenic bone graft (ABG) and bone substitutes on preventing ...
Po-Hsin Chou, Hsi-Hsien Lin, Yu-Cheng Yao, Ming-Chau Chang, Chien-Lin Liu, Shih-Tien Wang   +5 more
doaj   +1 more source

Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis

Critical Care Medicine, 2016
Objectives: The objective of this systematic review and meta-analysis was to assess acute kidney injury with combination therapy of vancomycin plus piperacillin-tazobactam, in general, adult patients and in critically ill adults.
Megan K. Luther, T. Timbrook, A. Caffrey, D. Dosa, T. Lodise, K. LaPlante   +5 more
semanticscholar   +1 more source

Study of antibiotic efficacy of topical vancomycin powder in treatment of infected mandibular fractures and soft tissue surgical site infections

Journal of Family Medicine and Primary Care, 2019
Aims and Objective: To study the antibiotic efficacy of topical vancomycin in infected mandibular fracture treatment and its effect in preventing surgical site infections.
Geeta Singh, Deepak Passi, Deepti Daga, Abhigyan Manas, U Vignesh, Sujay Milind Bhave   +5 more
doaj   +1 more source

Vancomycin Revisited - 60 years later

Frontiers in Public Health, 2014
Vancomycin is one of the older antibiotics that has been now in clinical use close to 60 years. Earlier on, vancomycin was associated with many side effects including vestibular and renal, most likely due to impurities contained .in early vancomycin lots.
Ethan eRubinstein, Yoav eKeynan
doaj   +1 more source

Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection

JAMA Internal Medicine, 2017
Importance Metronidazole hydrochloride has historically been considered first-line therapy for patients with mild to moderate Clostridium difficile infection (CDI) but is inferior to vancomycin hydrochloride for clinical cure.
V. Stevens, R. Nelson, Elyse Schwab-Daugherty, K. Khader, Makoto M. Jones, K. Brown, T. Greene, L. D. Croft, M. Neuhauser, P. Glassman, M. Goetz, M. Samore, M. Rubin   +12 more
semanticscholar   +1 more source

Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations

Pharmacology Research & Perspectives, 2018
Vancomycin is a fundamental antibiotic in the management of severe Gram‐positive infections. Inappropriate vancomycin dosing is associated with therapeutic failure, bacterial resistance and toxicity.
J. Monteiro, S. R. Hahn, J. Gonçalves, P. Fresco   +3 more
semanticscholar   +1 more source

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia

BMC Infectious Diseases, 2011
Background The high prevalence of methicillin-resistant S. aureus (MRSA) has led clinicians to select antibiotics that have coverage against MRSA, usually vancomycin, for empiric therapy for suspected staphylococcal infections.
McGregor Jessina C, Shardell Michelle D, Johnson J Kristie, Harris Anthony D, Furuno Jon P, Schweizer Marin L, Thom Kerri A, Cosgrove Sara E, Sakoulas George, Perencevich Eli N   +9 more
doaj   +1 more source

Insights into Key Interactions between Vancomycin and Bacterial Cell Wall Structures

ACS Omega, 2018
Vancomycin is a glycopeptide antibiotic used for the treatment of serious infections by Gram-positive pathogens. Vancomycin inhibits cell wall biosynthesis by targeting the d-Ala-d-Ala terminus of peptidoglycan (PG).
Feng Wang, Hongyu Zhou, O. Olademehin, S. Kim, Peng Tao   +4 more
semanticscholar   +1 more source